One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 3months
-
http://medilib.ir
- Duration of Time : 93 Day
Price : 100$- Special Price : 50$
Overall Survival with Neoadjuvant Nivolumab plus Chemotherapy in Lung Cancer
doi : 10.1056/NEJMoa2502931
Elinzanetant for Vasomotor Symptoms from Endocrine Therapy for Breast Cancer
doi : 10.1056/NEJMoa2415566
Phase 3 Trial of Inhaled Molgramostim in Autoimmune Pulmonary Alveolar Proteinosis
doi : 10.1056/NEJMoa2410542
Adjuvant Cemiplimab or Placebo in High-Risk Cutaneous Squamous-Cell Carcinoma
doi : 10.1056/NEJMoa2502449
Medical Education: Educational Strategies for Clinical Supervision of Artificial Intelligence Use
doi : 10.1056/NEJMra2503232
Menopausal Symptom Management in Breast Cancer Survivors — A Promising New Option
doi : 10.1056/NEJMe2506475
Science behind the Study: GM-CSF in Autoimmune Pulmonary Alveolar Proteinosis
doi : 10.1056/NEJMe2508174
Targeted Therapy of CAR+ T-Cell Lymphoma after Anti-BCMA CAR T-Cell Therapy
doi : 10.1056/NEJMc2504588
Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer
doi : 10.1056/NEJMx250003
